A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System (PARACHUTE IV)
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Type d'étude
Type d'étude
Inscription (Réel)
Inscription
Phase
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6E 1M7
- St. Paul's Hospital
-
-
-
-
Arizona
-
Phoenix, Arizona, États-Unis, 85013
- Arizona Heart
-
Tucson, Arizona, États-Unis, 85724
- University of Arizona Medical Center
-
-
Arkansas
-
Little Rock, Arkansas, États-Unis, 72211
- Arkansas Heart
-
-
California
-
Los Angeles, California, États-Unis, 90033
- University of Southern California (USC)
-
Los Angeles, California, États-Unis, 90069
- Cedars-Sinai Medical Center
-
Sacramento, California, États-Unis, 95817
- UC Davis Medical Center
-
-
Florida
-
Clearwater, Florida, États-Unis, 33756
- Morton Plant Hospital - Heart and Vascular Institute of Florida
-
Delray Beach, Florida, États-Unis, 33444
- Delray Medical Center
-
Tallahassee, Florida, États-Unis, 32308
- Tallahassee Research Institute
-
Tampa, Florida, États-Unis, 33613
- Florida Hospital Tampa - Pepin Heart Institute
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30309
- Piedmont Atlanta Hospital
-
-
Idaho
-
Coeur d'Alene, Idaho, États-Unis, 83814
- Kootenai Heart Clinics
-
-
Illinois
-
Evanston, Illinois, États-Unis, 60201
- Evanston Hospital
-
Naperville, Illinois, États-Unis, 60566
- Advocate Medical Group - Midwest Heart Foundation
-
Springfield, Illinois, États-Unis, 62701
- Prairie Education and Research Cooperative - St. John's Hospital
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46260
- St. Vincent Heart Center of Indiana
-
-
Iowa
-
Des Moines, Iowa, États-Unis, 50266
- Iowa Heart Center
-
Iowa City, Iowa, États-Unis, 52242-1081
- University of Iowa Hospitals and Clinics
-
-
Kansas
-
Kansas City, Kansas, États-Unis, 66160
- University of Kansas Hospital
-
-
Kentucky
-
Lexington, Kentucky, États-Unis, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, États-Unis, 40504
- St Joseph Hospital/Kentucky One
-
Louisville, Kentucky, États-Unis, 40202
- Jewish Hospital/Louisville
-
-
Louisiana
-
Houma, Louisiana, États-Unis, 70360
- Cardiovascular Institute of the South
-
New Orleans, Louisiana, États-Unis, 70121
- Ochsner Clinic Foundation
-
New Orleans, Louisiana, États-Unis, 70112
- LSU Health Sciences Center
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02111
- Tufts Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, États-Unis, 48197
- St. Joseph Mercy-Michigan Heart
-
Midland, Michigan, États-Unis, 48670
- MidMichigan Medical Center
-
-
Minnesota
-
Minneapolis, Minnesota, États-Unis, 55455
- University of Minnesota Medical Center
-
Saint Paul, Minnesota, États-Unis, 55102
- United Heart and Vascular Clinic
-
-
Missouri
-
Kansas City, Missouri, États-Unis, 64111
- St. Luke's MAHI
-
-
Nebraska
-
Lincoln, Nebraska, États-Unis, 68526
- Nebraska Heart Hospital
-
-
New Jersey
-
Browns Mills, New Jersey, États-Unis, 08015
- Deborah Heart and Lung Center
-
Hackensack, New Jersey, États-Unis, 07601
- Hackensack UMC
-
-
New York
-
Buffalo, New York, États-Unis, 14203
- Gates Vascular Institute/Buffalo General Hospital
-
New York, New York, États-Unis, 10029
- Mount Sinai Medical Center
-
New York, New York, États-Unis, 10065
- New York Presbyterian Hospital - Cornell Campus
-
Rochester, New York, États-Unis, 14643
- Univ. Of Rochester Medical Center
-
-
North Carolina
-
Winston-Salem, North Carolina, États-Unis, 27157
- Wake Forest Baptist Health
-
-
Ohio
-
Cincinnati, Ohio, États-Unis, 45219
- The Christ Hospital Lindner Research Center
-
Cleveland, Ohio, États-Unis, 44106
- University Hospitals
-
Columbus, Ohio, États-Unis, 43210
- The Ohio State University
-
Columbus, Ohio, États-Unis, 43214
- Ohio Health Research Institute/Riverside Methodist Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, États-Unis, 73120
- Oklahoma Heart Hospital
-
Oklahoma City, Oklahoma, États-Unis, 73112
- Integris Baptist Medical Center
-
-
Pennsylvania
-
Lancaster, Pennsylvania, États-Unis, 17062
- Lancaster General Hospital
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19141
- Einstein Healthcare Network Cardiology
-
Pittsburgh, Pennsylvania, États-Unis, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, États-Unis, 15213
- University of Pittsburgh Medical Center - Presbyterian Hospital
-
Wormleysburg, Pennsylvania, États-Unis, 17043
- Pinnacle Health Cardiovascular Institute
-
-
Rhode Island
-
Providence, Rhode Island, États-Unis, 02906
- The Miriam Hospital
-
-
Tennessee
-
Kingsport, Tennessee, États-Unis, 37660
- Wellmont Holston Valley Medical Center
-
Knoxville, Tennessee, États-Unis, 37934
- Tennova Healthcare - Turkey Creek Medical Center
-
Nashville, Tennessee, États-Unis, 37232
- Vanderbilt University
-
Nashville, Tennessee, États-Unis, 37205
- Saint Thomas West Hospital
-
-
Texas
-
Austin, Texas, États-Unis, 78745
- Texas Cardiac Arrhythmia Research Foundation
-
Houston, Texas, États-Unis, 77030
- Memorial Hermann Hospital
-
Houston, Texas, États-Unis, 77030
- Texas Heart Institute at St. Luke's Episcopal Hospital
-
Houston, Texas, États-Unis, 77056
- The Methodist Hospital
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84132
- University of Utah
-
-
Virginia
-
Falls Church, Virginia, États-Unis, 22042
- Inova Heart and Vascular, Fairfax
-
Norfolk, Virginia, États-Unis, 23507
- Sentara Cardiovascular Research Institute
-
Richmond, Virginia, États-Unis, 23298
- Virginia Commonwealth University Medical Center
-
-
Washington
-
Seattle, Washington, États-Unis, 98122
- Swedish Medical Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, États-Unis, 53215
- Aurora St. Luke's Medical Center
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Candidates for this study must meet ALL of the following inclusion criteria:
Clinical Inclusion Criteria:
- Age ≥ 18 and ≤ 79 years.
- Body Mass Index (BMI) ≤ 40.
- Symptomatic ischemic heart failure (New York Heart Association (NYHA) Class III or "ambulatory" Class IV as determined through the use of the SAS) post Myocardial Infarction (MI) in the Left Anterior Descending (LAD) territory at least 60 days prior to enrollment.
- Patient is not hospitalized at the time of enrollment.
- Receiving appropriate medical treatment for heart failure according to the current American College of Cardiology (ACC)/American Heart Association (AHA) Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult during the three months prior to enrollment.
- The patient or the patient's legal representative has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent as approved by the Institutional Review Board (IRB)/Ethics Committee (EC) of the respective clinical site.
- The patient and the treating physician agree that the patient will return for all required post-procedure follow-up visits.
Inclusion Criteria based on Imaging:
- 15% ≤ Left Ventricular Ejection Fraction (LVEF) ≤ 35% by Transthoracic Echocardiogram (TTE).
- Post LV MI structural heart dysfunction represented by LV wall motion abnormality (WMA) by TTE.
- Left ventricle must have appropriate anatomy (size and morphology) for implant placement using Cardiac Computed Tomography (CT) and confirmed by LV gram
Candidates will be excluded from the study if ANY of the following conditions apply:
Clinical Exclusion Criteria:
- Untreated clinically significant coronary artery disease requiring revascularization.
- Cardiogenic shock within 72 hours of enrollment.
- Patient has received a pacemaker, Implantable Cardioverter Defibrillator (ICD), or Cardiac Resynchronization Therapy (CRT) within 60 days of enrollment.
- Excessive wall motion abnormalities outside the anteroapical region.
- Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack (TIA).
- End stage renal disease requiring chronic dialysis.
- Obstructive Sleep Apnea (OSA): unless compliant on CPAP therapy or successful surgery.
- Hemoglobin < 10 g/dl (female), < 12 g/dl (male) or Creatinine > 2.5mg/dl.
- Blood dyscrasia, history of bleeding diathesis or coagulopathy, or hypercoagulable states.
- Active peptic ulcer or GI bleeding within the past 3 months.
- A known hypersensitivity or contraindication to aspirin, warfarin, nitinol (titanium and nickel alloy), or sensitivity to contrast media, which cannot be adequately pre-medicated.
- Ongoing sepsis, including active endocarditis.
- Life expectancy < 1 year due to associated non-cardiac co-morbid conditions or currently on the heart transplant lists.
- Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the patient from appropriate consent.
- Currently participating in an investigational drug or another device study (prior to primary endpoint reached).
- Female patients with childbearing potential and a positive urine pregnancy test .
Anatomical Exclusion Criteria:
- Pre-existing prosthetic heart valve in mitral or aortic position.
- Valvular stenosis or regurgitation (tricuspid, aortic or mitral) > 2+.
- Presence of anatomic anomalies (including severe calcification) detected by cardiac imaging (echocardiogram, Computed Tomography (CT), or LV gram) preventing unimpeded deployment and/or operation of the Parachute Implant
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Parachute Implant and All Appropriate Medical Therapy (AAMT)
|
CardioKinetix Parachute implant and all appropriate medical therapy
|
|
Aucune intervention: All Appropriate Medical Therapy (AAMT)
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Death or re-hospitalization for Worsening Heart Failure (WHF)
Délai: At least 1 year
|
At least 1 year
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chercheur principal: Marco A Costa, MD, PhD, University Hospitals
- Chercheur principal: Leslie Saxon, MD, University of Southern California
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Réel)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- VA0956
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .